Lipid metabolite biomarkers in cardiovascular disease: Discovery and biomechanism translation from human studies

P McGranaghan, JA Kirwan, MA Garcia-Rivera… - Metabolites, 2021 - mdpi.com
Lipids represent a valuable target for metabolomic studies since altered lipid metabolism is
known to drive the pathological changes in cardiovascular disease (CVD). Metabolomic …

Clinical potential of adrenomedullin signaling in the cardiovascular system

L Bálint, NP Nelson-Maney, Y Tian, SD Serafin… - Circulation …, 2023 - Am Heart Assoc
Numerous clinical studies have revealed the utility of circulating AM (adrenomedullin) or MR-
proAM (mid-regional proAM 45-92) as an effective prognostic and diagnostic biomarker for a …

Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases

T Kita, K Kitamura - Hypertension Research, 2022 - nature.com
Adrenomedullin (AM) is a vasodilative peptide with various physiological functions,
including the maintenance of vascular tone and endothelial barrier function. AM levels are …

Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases

D Mu, J Cheng, L Qiu, X Cheng - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Copeptin is the carboxyl-terminus of the arginine vasopressin (AVP) precursor peptide. The
main physiological functions of AVP are fluid and osmotic balance, cardiovascular …

Vasopressin and breathing: review of evidence for respiratory effects of the antidiuretic hormone

M Proczka, J Przybylski… - Frontiers in Plant …, 2021 - frontiersin.org
Vasopressin (AVP) is a key neurohormone involved in the regulation of body functions. Due
to its urine-concentrating effect in the kidneys, it is often referred to as antidiuretic hormone …

Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure

J Veskovic, M Cvetkovic, E Tahirovic… - BMC Cardiovascular …, 2023 - Springer
Background Chronic heart failure (CHF) is a severe condition, often co-occurring with
depression and anxiety, that strongly affects the quality of life (QoL) in some patients …

Differential associations of A-/B-type natriuretic peptides with cardiac structure, function, and prognosis in heart failure

ESJ Tan, SP Chan, OW Liew, JPC Chong… - Heart Failure, 2024 - jacc.org
Background Natriuretic peptide (NP) elevations are prognostic in heart failure (HF), but
relative atrial NP deficiency in acute HF has been suggested. Objectives The authors …

Biological variation estimates for plasma copeptin and clinical implications

KW Choy, A Carobene, TP Loh… - The journal of …, 2024 - academic.oup.com
Background Plasma copeptin measurement is useful for the differential diagnoses of
polyuria-polydipsia syndrome. It has also been proposed as a prognostic marker for …

Biomarkers of volume overload and edema in heart failure with reduced ejection fraction

RM Chiorescu, RD Lazar, SB Buksa… - Frontiers in …, 2022 - frontiersin.org
From a pathogenetic point of view, heart failure (HF) is characterized by the activation of
several neurohumoral pathways with a role in maintaining the cardiac output and the …

Advances in congestive heart failure biomarkers

IK Mohan, KSSS Baba, R Iyyapu… - Advances in Clinical …, 2023 - Elsevier
Congestive heart failure (CHF) is the leading cause of morbidity and mortality in the elderly
worldwide. Although many biomarkers associated with in heart failure, these are generally …